NZ291223A - Medicament containing ibuprofen and codeine, and a carrier containing a hydrogenated vegetable oil as a lubricant - Google Patents

Medicament containing ibuprofen and codeine, and a carrier containing a hydrogenated vegetable oil as a lubricant

Info

Publication number
NZ291223A
NZ291223A NZ291223A NZ29122395A NZ291223A NZ 291223 A NZ291223 A NZ 291223A NZ 291223 A NZ291223 A NZ 291223A NZ 29122395 A NZ29122395 A NZ 29122395A NZ 291223 A NZ291223 A NZ 291223A
Authority
NZ
New Zealand
Prior art keywords
codeine
hydrogenated vegetable
lubricant
vegetable oil
ibuprofen
Prior art date
Application number
NZ291223A
Other languages
English (en)
Inventor
Brian Holmes
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9417041A external-priority patent/GB9417041D0/en
Priority claimed from GB9419921A external-priority patent/GB9419921D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NZ291223A publication Critical patent/NZ291223A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NZ291223A 1994-08-23 1995-08-16 Medicament containing ibuprofen and codeine, and a carrier containing a hydrogenated vegetable oil as a lubricant NZ291223A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9417041A GB9417041D0 (en) 1994-08-23 1994-08-23 Improved formulations
GB9419921A GB9419921D0 (en) 1994-10-04 1994-10-04 Improved formulations
PCT/GB1995/001947 WO1996005834A1 (en) 1994-08-23 1995-08-16 Improved pharmaceutical formulations containing ibuprofen and codeine

Publications (1)

Publication Number Publication Date
NZ291223A true NZ291223A (en) 1998-12-23

Family

ID=26305507

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ291223A NZ291223A (en) 1994-08-23 1995-08-16 Medicament containing ibuprofen and codeine, and a carrier containing a hydrogenated vegetable oil as a lubricant

Country Status (24)

Country Link
EP (1) EP0777477B1 (de)
JP (1) JP3874793B2 (de)
KR (1) KR100397082B1 (de)
CN (1) CN1083265C (de)
AT (1) ATE227574T1 (de)
AU (1) AU699224B2 (de)
BG (1) BG63329B1 (de)
BR (1) BR9508760A (de)
CA (1) CA2156768A1 (de)
CZ (1) CZ287558B6 (de)
DE (1) DE69528838T2 (de)
DK (1) DK0777477T3 (de)
ES (1) ES2187566T3 (de)
HU (1) HU227759B1 (de)
MX (1) MX9701390A (de)
NO (1) NO322200B1 (de)
NZ (1) NZ291223A (de)
PL (1) PL181215B1 (de)
PT (1) PT777477E (de)
RU (1) RU2140782C1 (de)
SK (1) SK282183B6 (de)
TW (1) TW493984B (de)
UA (1) UA42781C2 (de)
WO (1) WO1996005834A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608073B1 (en) 1998-10-14 2003-08-19 New Millennium Pharmaceutical Research, Inc. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
JP2001253826A (ja) * 2000-03-09 2001-09-18 Maruzen Pharmaceut Co Ltd 内服用剤
US7183410B2 (en) 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
US20040253311A1 (en) * 2002-12-18 2004-12-16 Roger Berlin Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
US8227476B2 (en) 2005-08-03 2012-07-24 Sprout Pharmaceuticals, Inc. Use of flibanserin in the treatment of obesity
CA2626134C (en) 2005-10-29 2013-12-24 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
ZA200803566B (en) * 2005-12-12 2009-10-28 Adcock Ingram Ltd Pharmaceutical compositions
WO2008000760A1 (en) 2006-06-30 2008-01-03 Boehringer Ingelheim International Gmbh Flibanserin for the treatment of urinary incontinence and related diseases
EP2039359A4 (de) * 2006-07-12 2009-11-25 Aska Pharm Co Ltd Analgetisches mittel
EP2054041A2 (de) 2006-08-14 2009-05-06 Boehringer Ingelheim International GmbH Formulierungen von flibanserin und herstellungsverfahren dafür
AR062321A1 (es) 2006-08-25 2008-10-29 Boehringer Ingelheim Int Sistema de liberacion controlada y metodo para fabricarlo
TW200820994A (en) * 2006-10-05 2008-05-16 Kowa Co Solid preparation containing ibuprofen and tranexamic acid
CL2008002693A1 (es) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad
PT2279731E (pt) * 2008-04-23 2013-08-30 Farmasierra Mfg S L Composição farmacêutica melhorada contendo ibuprofeno e codeína
ES2365961B1 (es) 2010-03-30 2013-01-24 Farmasierra Manufacturing S.L. Formulación farmacéutica a base de ibuprofeno y codeína de estabilidad mejorada.
KR101317809B1 (ko) 2011-06-07 2013-10-16 한미약품 주식회사 암세포의 성장을 억제하는 아마이드 유도체 및 비금속염 활택제를 포함하는 약학 조성물
KR20140096571A (ko) 2013-01-28 2014-08-06 한미약품 주식회사 1-(4-(4-(3,4-디클로로-2-플루오로페닐아미노)-7-메톡시퀴나졸린-6-일옥시)피페리딘-1-일)프로프-2-엔-1-온의 제조방법
BR112017003430A2 (pt) 2014-08-28 2017-11-28 Sanofi Aventis De Mexico Sa De Cv comprimido revestido com filme para o tratamento de dor aguda
CN105395508B (zh) * 2015-12-14 2018-06-29 西南药业股份有限公司 一种洛芬待因复方制剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4571400A (en) * 1984-12-18 1986-02-18 Belleview Pharmaceutical, Inc. Dihydrocodeine/ibuprofen pharmaceutical compositions and method
GB8905815D0 (en) * 1989-03-14 1989-04-26 Beecham Group Plc Medicament
GB9121204D0 (en) * 1991-10-04 1991-11-20 Euro Celtique Sa Medicament

Also Published As

Publication number Publication date
MX9701390A (es) 1998-06-30
WO1996005834A1 (en) 1996-02-29
UA42781C2 (uk) 2001-11-15
KR970705389A (ko) 1997-10-09
BR9508760A (pt) 1998-01-13
ATE227574T1 (de) 2002-11-15
EP0777477A1 (de) 1997-06-11
SK282183B6 (sk) 2001-11-06
PL181215B1 (pl) 2001-06-29
TW493984B (en) 2002-07-11
ES2187566T3 (es) 2003-06-16
EP0777477B1 (de) 2002-11-13
BG63329B1 (bg) 2001-10-31
PL318807A1 (en) 1997-07-07
NO322200B1 (no) 2006-08-28
HU227759B1 (en) 2012-02-28
NO970782L (no) 1997-02-20
BG101252A (en) 1998-02-27
DE69528838D1 (de) 2002-12-19
RU2140782C1 (ru) 1999-11-10
NO970782D0 (no) 1997-02-20
AU3228995A (en) 1996-03-14
PT777477E (pt) 2003-03-31
SK23697A3 (en) 1997-08-06
AU699224B2 (en) 1998-11-26
JP3874793B2 (ja) 2007-01-31
CZ287558B6 (en) 2000-12-13
DE69528838T2 (de) 2003-07-10
CN1083265C (zh) 2002-04-24
CN1159754A (zh) 1997-09-17
JPH10504557A (ja) 1998-05-06
DK0777477T3 (da) 2003-03-17
HUT77385A (hu) 1998-04-28
CZ54697A3 (en) 1997-12-17
CA2156768A1 (en) 1996-02-24
KR100397082B1 (ko) 2004-02-11

Similar Documents

Publication Publication Date Title
NZ291223A (en) Medicament containing ibuprofen and codeine, and a carrier containing a hydrogenated vegetable oil as a lubricant
NZ328898A (en) Sustained release formulation containing collagen and glycosaminoglycan additives
IL127244A0 (en) Pharmaceutical for treatment of neurological and neuropsychiatric disorders
MY112915A (en) Multiple unit tableted dosage form 1
EP0744942A4 (de) Hydrogelformulierung mit gesteuerter freisetzung
PL337126A1 (en) Novel compounds
EP1025845A3 (de) Tabletten mit Hydromorphon
AU3632497A (en) Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
SG64372A1 (en) Rapamycin derivatives
MX9707535A (es) Uso de derivados de vitamina d2 o de vitamina d4 en la preparacion de un farmaco para el tratamiento de hiperparatiroidismo secundario.
DE69510755D1 (de) Ölsäurereiche Polyolester, diese enthaltende Kompositionen und funktionelle Schmierfluide und Fette
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
EP0793660A4 (de) 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1-dioxiden, zusammensetzung und deren verwendung
ES2177644T3 (es) Procedimiento para la resolucion de etodolac utilizando derivados de glucamina.
IL131407A0 (en) Tetrahydropyrido compounds medicaments containing the same and the use thereof
PL315127A1 (en) Deuterised biologically active substances for percutaneous administration
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
IL110011A0 (en) Pharmaceutical compositions for the treatment of schizophrenia
AR021186A1 (es) Compuestos de 4-amino-1-aril-piridin-2-ona de efecto anticonvulsivante, procedimiento para su elaboracion, preparaciones farmaceuticas que incluyendichos compuestos y utilizacion de los compuestos mencionados para obtener dichas preparaciones.
UA42749C2 (uk) N,n-діетил-8,8-дипропіл-2-азаспіро[4,5]декан-2-пропанамін дималеат, фармацевтична композиція, спосіб лікування
WO2001021178A3 (en) Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs
AU5857899A (en) Use of tgf-beta inhibitors for treating cerebral disorders
UA9586C2 (uk) Мастило для механічної обробки металів
JO1880B1 (en) Format 1 for multi-unit calibration discs
WO2003014328A3 (en) Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired